Significant progress in three targeted areas of MosaiQ development – COVID-19 antibody test, potential new applications, and transfusion diagnostics Ten commercial placements of MosaiQ platform in ...

Greetings and welcome to Quotient Limited Third Quarter Fiscal Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will ...

Transfusion Dx: The Expanded Immunohematology CE regulatory dossier has been submitted with 20 specificities; and Expanded Serological Disease Screening immunoassay microarray is progressing towards ...

Edinburgh-based Alba Bioscience announced a major investment today (Tuesday 16 September 2008) to create and secure 16 high value research and development jobs and support the development of novel ...

Alba Bioscience, the privatised former commer- cial arm of the Scottish National Blood Trans-fusion Service, is to become a subsidiary of a new bio- diagnostics unit of parent Quotient Bioscience - a ...

Alba by Quotient: Submitted first Alba by Quotient IVDR filing. The new distributor partners for MosaiQ are expected to sell Alba by Quotient portfolio expanding Alba's geographic footprint. Financial ...

NEWTOWN, Pa. & EDINBURGH, Scotland--(BUSINESS WIRE)--Quotient Biodiagnostics Holdings Limited ("Quotient"), a global transfusion diagnostics Group, is pleased to announce that it has completed an ...

NEWTOWN, Pa.--(BUSINESS WIRE)--Quotient Biodiagnostics, Inc. (“Quotient”), a supplier of innovative and high-quality transfusion diagnostic products to hospitals, blood banks and other healthcare ...

Leader in the development and manufacture of transfusion diagnostic products awarded prestigious Queen's Award for outstanding achievement in international trade Quotient Limited (NASDAQ:QTNT), a ...

JERSEY, Channel Islands, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company (Quotient or the Company), headquartered in Eysins, Switzerland, today ...

Expanded MosaiQ IH microarray EU launch planned for fourth quarter CY2021 Sales of Alba by Quotient reagents exceed guidance Strong cash position in place to carry us into commercialization JERSEY, ...